Pay to Marwadi

Company Profile

HEALTHCARE GLOBAL ENTERPRISES LTD.

NSE : HCGBSE : 539787ISIN CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse : HCG
BSE362.85-1.9 (-0.52 % )
PREV CLOSE (Rs.) 364.75
OPEN PRICE (Rs.) 364.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 8504
TODAY'S LOW / HIGH (Rs.)358.65 364.80
52 WK LOW / HIGH (Rs.)257.05 401
NSE362.70 -1.35 (-0.37 % )
PREV CLOSE(Rs.) 364.05
OPEN PRICE (Rs.) 366.00
BID PRICE (QTY) 362.70 (29 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 99352
TODAY'S LOW / HIGH(Rs.) 358.40 366.05
52 WK LOW / HIGH (Rs.)258 401

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) 2.86
P/E Ratio 126.67
Book Value (Rs.) 85.17
Face Value (Rs.) 10
MCap (Rs. in Mn) 50541.26
Price/Earning (TTM) 38.30
Price/Sales (TTM) 4.69
Price/Book (MRQ) 4.26
PAT Margin (%) 4.00
ROCE (%) 8.02
Incorporation Year : 1998

Management Info :

B S Ajai Kumar - Chairman - Managing Director

Registered Office :

Address : H C G Tower, No.8,P. Kalinga Rao Road,Sampangi Rama Nagar,
Bengaluru,
Karnataka-560027

Phone : 080 - 33669999

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
09Mar03-09-2024$HealthCare Global Enterprises informs about Acquisition HealthCare Global Enterprise

HealthCare Global Enterprises informed about the execution of Transfer of Partnership Interest Agreement (TPIA) for the acquisition of minority interest in HCG EKO Oncology LLP (HCG EKO LLP).

The above information is a part of company’s filings submitted to BSE. 


HealthCare Global Enterprises informed about the execution of T..
26Feb02-26-2024$HealthCare Global Enterprises submits analyst meet intimation HealthCare Global Enterprise
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, HealthCare Global Enterprises has informed that the officials of the Company will be meeting Investors/ Analysts (Participants) on February 28, 2024 as per the details enclosed.

The above information is a part of company’s filings submitted to BSE.
Pursuant to the relevant provisions of SEBI (Listing Obligation..
30Dec12-30-2023$HealthCare Global Enterprises informs about newspaper publication HealthCare Global Enterprise
HealthCare Global Enterprises has attached copies of newspaper advertisement published in Business Standard (English) and Vijayawani (Kannada) on December 30, 2023 with regard to postal ballot notice dated December 29, 2023.

The above information is a part of company’s filings submitted to BSE.
HealthCare Global Enterprises has attached copies of newspaper..
18Nov11-18-2023$HealthCare Global Enterprises informs about earnings call transcript HealthCare Global Enterprise
HealthCare Global Enterprises has informed that it enclosed Transcript of the earnings call held on November 10, 2023 with analysts/investors to discuss on the unaudited financial results for the quarter and half year ended Sept 30, 2023.

The above information is a part of company’s filings submitted to BSE.


HealthCare Global Enterprises has informed that it enclosed Tra..
05Oct10-05-2023$Nazara Technologies, Strides Pharma Science and TCPL Packaging to see some action today Nazara Technologies, Strides

Nazara Technologies’ material subsidiary -- Nodwin Gaming’s Singapore subsidiary has acquired a 100% stake in game marketing agency PublishME for a sum of $2 million from its existing shareholders Nazara Technologies and Ozgur Ozalp. The integration and acquisition of PublishME into NODWIN Gaming's global emerging market network are poised to enhance NODWIN Gaming’s existing solutions capabilities for publishers and brands alike. This acquisition will provide the essential tailwinds for NODWIN Gaming to drive its mission of leading the emerging market sports media landscape.

Strides Pharma Science’s step-down wholly owned subsidiary -- Strides Pharma Global has received approval for Efavirenz (600mg), Emtricitabine (200mg), Tenofovir Disproxil Fumurate (300mg) (EET) tablets from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Atripla Tablets of Gilead Sciences LLC. The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products.

TCPL Packaging has further acquired 38600 shares of its subsidiary company namely Creative Offset Printers (COPPL) from one of the promoters of COPPL at a consideration of Rs 1.85 crore. Post-acquisition / transfer of shares as aforesaid, the company holds 94.67% of the share capital of COPPL.

HealthCare Global Enterprises has completed the acquisition of SRJ Health Care’s comprehensive cancer care center in Indore, Madhya Pradesh on a slump sale basis and Amrish Oncology Services’ Radiation business in Indore, Madhya Pradesh on a slump sale basis (collectively known as Business Undertaking) on October 04, 2023. Accordingly, the Business Undertaking would operate as a business unit of the Company, effective from October 04, 2023.  

Marine Electricals (India) has received order amounting to Rs 2.28 crore (excluding taxes) from Cochin Shipyard, Kochi for supply and services of Addressable Food Alarm System (AFAS) for ASW SWC. The delivery period shall be over a period of 2 years.

Samvardhana Motherson International has raised Rs 1500 crore through allotment of 1,50,000 Rated, Listed, Unsecured, Redeemable, Non-Convertible Debentures (NCDs) having face value of Rs 1,00,000 each on private placement basis on October 4, 2023. The said NCDs will be listed on the Wholesale Debt Market segment of BSE. 

Exide Industries has invested Rs 340 crore by the way of subscription in the equity share capital of Exide Energy Solutions (EESL), a wholly owned subsidiary on right basis. EESL is in the process of setting up a plant for manufacturing & selling lithium-ion battery cells, modules and pack business. The company has made further investment by subscribing to equity shares offered by EESL on a rights basis to fund its green field project and meet various funding requirements. With the current investment, EIL shareholding in EESL remains unchanged at 100%.

Nazara Technologies’ material subsidiary -- Nodwin Gaming’s..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit83.3401.899999999999
Gross Profit 149.5 576.199999999999
Operating Profit 522.51910.8
Net Sales 2672.110075.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Dr Agarwals Eye Hsp (BSE)
 3457.65 (4.05%)
M.Cap ( in Cr)
1625.10
Kovai Medical Center (BSE)
 4118.45 (1.37%)
M.Cap ( in Cr)
4506.52
RainbowChildrenS Med (BSE)
 1343.40 (3.59%)
M.Cap ( in Cr)
13635.74
Krishna Inst.Medi (BSE)
 2001.20 (1.91%)
M.Cap ( in Cr)
16015.16
Metropolis Health. (BSE)
 1829.50 (2.03%)
M.Cap ( in Cr)
9372.31
Shareholding Pattern More
PROMOTERS 71.28 %
MUTUAL FUNDS/UTI 6.49 %
NON-INSTITUTION 13.46 %
FI/BANKS/INSURANCE 0.14 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes